Long-term effects of anti-retroviral therapy in acute HIV infection

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800015006

Enrollment

Unknown

Registered

2018-02-28

Start date

2018-04-01

Completion date

Unknown

Last updated

2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infections

Interventions

Long-term treatment Group:2NRTIs (TDF+3TC)+EFV or LPV/r

Eligibility

Sex/Gender

Male

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who initiated anti-retroviral therapy during acute HIV infection (enrolled in ChiCTR-ONRC-13003483) and maintained follow up and treatment for more than one year; 2. Male, with self-reported sexual behavior with men; 3. Aged 18-65 years old; 4. Subjects who signed the informed consent and would like to follow up; 5. Subjects with no plan to resettle during the trial.

Exclusion criteria

Exclusion criteria: 1. Patients who participate in any other HIV intervention study or experimental drug study; 2. Patients with mental retardation or cannot communicate with their doctors; 3. Serious alcoholics; 4. Not of Chinese nationality.

Design outcomes

Primary

Measure	Time frame
HIV viral load;CD4 T cell count;	—

Secondary

Measure	Time frame
HIV reservoir;	—

Countries

China

Contacts

Public ContactHong Shang

hongshang100@hotmail.com+86 13889875242

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026